The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells

M. Hayashi, Y. Yamaji, Y. Nakazato, T. Saruta

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

It has been reported that calcium channel blockers (CCBs) have an inhibitory action on cell growth and transcriptional changes induced by cytokines and hormones. In this study, we examined the effects of CCBs on nuclear factor kappa B (NFκB), which plays a key role in the intracellular signaling of various growth factors and cytokines. The activity of NFκB was determined by luciferase assay with the transfection of the reporter gene, which has six NFκB-recognizing sequences in the upstream of herpes simplex virus thymidine kinase promoter. In cultured human mesangial cells, increased intracellular calcium concentration by calcium ionophore, A23187, showed a stimulatory effect on the phorbor 12-myristate 13-acetate (PMA)-induced activation of NFκB, while L-type calcium channel agonist, Bay K 8644, did not have any significant effects on either basal or PMA-stimulated activity of NFκB. At a higher concentration (10 μM), nifedipine, verapamil, or efonidipine showed an inhibitory effect on the activation of NFκB by PMA and A23187, while at a lower concentration (1 μM), only efonidipine showed a significant inhibitory effect. From these results, we conclude that CCBs have an inhibitory effect on NFκB via the independent pathway of an L-type calcium channel and that the potency of this effect is variable among L-type calcium channel blockers.

Original languageEnglish
Pages (from-to)521-525
Number of pages5
JournalHypertension Research
Volume23
Issue number5
Publication statusPublished - 2000

Fingerprint

NF-kappa B
Calcium Channel Blockers
L-Type Calcium Channels
Myristic Acid
Acetates
Calcimycin
Calcium Channel Agonists
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Cytokines
Mesangial Cells
Thymidine Kinase
Calcium Ionophores
Simplexvirus
Nifedipine
Verapamil
Luciferases
Reporter Genes
Transfection
Intercellular Signaling Peptides and Proteins
Hormones

Keywords

  • Calcium channel blockers
  • Mesangium cells
  • Nuclear factor kappa B

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Hayashi, M., Yamaji, Y., Nakazato, Y., & Saruta, T. (2000). The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells. Hypertension Research, 23(5), 521-525.

The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells. / Hayashi, M.; Yamaji, Y.; Nakazato, Y.; Saruta, T.

In: Hypertension Research, Vol. 23, No. 5, 2000, p. 521-525.

Research output: Contribution to journalArticle

Hayashi, M, Yamaji, Y, Nakazato, Y & Saruta, T 2000, 'The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells', Hypertension Research, vol. 23, no. 5, pp. 521-525.
Hayashi, M. ; Yamaji, Y. ; Nakazato, Y. ; Saruta, T. / The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells. In: Hypertension Research. 2000 ; Vol. 23, No. 5. pp. 521-525.
@article{27b72be6f99e4734a631e84f1fd69598,
title = "The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells",
abstract = "It has been reported that calcium channel blockers (CCBs) have an inhibitory action on cell growth and transcriptional changes induced by cytokines and hormones. In this study, we examined the effects of CCBs on nuclear factor kappa B (NFκB), which plays a key role in the intracellular signaling of various growth factors and cytokines. The activity of NFκB was determined by luciferase assay with the transfection of the reporter gene, which has six NFκB-recognizing sequences in the upstream of herpes simplex virus thymidine kinase promoter. In cultured human mesangial cells, increased intracellular calcium concentration by calcium ionophore, A23187, showed a stimulatory effect on the phorbor 12-myristate 13-acetate (PMA)-induced activation of NFκB, while L-type calcium channel agonist, Bay K 8644, did not have any significant effects on either basal or PMA-stimulated activity of NFκB. At a higher concentration (10 μM), nifedipine, verapamil, or efonidipine showed an inhibitory effect on the activation of NFκB by PMA and A23187, while at a lower concentration (1 μM), only efonidipine showed a significant inhibitory effect. From these results, we conclude that CCBs have an inhibitory effect on NFκB via the independent pathway of an L-type calcium channel and that the potency of this effect is variable among L-type calcium channel blockers.",
keywords = "Calcium channel blockers, Mesangium cells, Nuclear factor kappa B",
author = "M. Hayashi and Y. Yamaji and Y. Nakazato and T. Saruta",
year = "2000",
language = "English",
volume = "23",
pages = "521--525",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells

AU - Hayashi, M.

AU - Yamaji, Y.

AU - Nakazato, Y.

AU - Saruta, T.

PY - 2000

Y1 - 2000

N2 - It has been reported that calcium channel blockers (CCBs) have an inhibitory action on cell growth and transcriptional changes induced by cytokines and hormones. In this study, we examined the effects of CCBs on nuclear factor kappa B (NFκB), which plays a key role in the intracellular signaling of various growth factors and cytokines. The activity of NFκB was determined by luciferase assay with the transfection of the reporter gene, which has six NFκB-recognizing sequences in the upstream of herpes simplex virus thymidine kinase promoter. In cultured human mesangial cells, increased intracellular calcium concentration by calcium ionophore, A23187, showed a stimulatory effect on the phorbor 12-myristate 13-acetate (PMA)-induced activation of NFκB, while L-type calcium channel agonist, Bay K 8644, did not have any significant effects on either basal or PMA-stimulated activity of NFκB. At a higher concentration (10 μM), nifedipine, verapamil, or efonidipine showed an inhibitory effect on the activation of NFκB by PMA and A23187, while at a lower concentration (1 μM), only efonidipine showed a significant inhibitory effect. From these results, we conclude that CCBs have an inhibitory effect on NFκB via the independent pathway of an L-type calcium channel and that the potency of this effect is variable among L-type calcium channel blockers.

AB - It has been reported that calcium channel blockers (CCBs) have an inhibitory action on cell growth and transcriptional changes induced by cytokines and hormones. In this study, we examined the effects of CCBs on nuclear factor kappa B (NFκB), which plays a key role in the intracellular signaling of various growth factors and cytokines. The activity of NFκB was determined by luciferase assay with the transfection of the reporter gene, which has six NFκB-recognizing sequences in the upstream of herpes simplex virus thymidine kinase promoter. In cultured human mesangial cells, increased intracellular calcium concentration by calcium ionophore, A23187, showed a stimulatory effect on the phorbor 12-myristate 13-acetate (PMA)-induced activation of NFκB, while L-type calcium channel agonist, Bay K 8644, did not have any significant effects on either basal or PMA-stimulated activity of NFκB. At a higher concentration (10 μM), nifedipine, verapamil, or efonidipine showed an inhibitory effect on the activation of NFκB by PMA and A23187, while at a lower concentration (1 μM), only efonidipine showed a significant inhibitory effect. From these results, we conclude that CCBs have an inhibitory effect on NFκB via the independent pathway of an L-type calcium channel and that the potency of this effect is variable among L-type calcium channel blockers.

KW - Calcium channel blockers

KW - Mesangium cells

KW - Nuclear factor kappa B

UR - http://www.scopus.com/inward/record.url?scp=0033794776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033794776&partnerID=8YFLogxK

M3 - Article

C2 - 11016808

AN - SCOPUS:0033794776

VL - 23

SP - 521

EP - 525

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 5

ER -